Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
about
Eyeblink classical conditioning and post-traumatic stress disorder - a model systems approach.The role of PKC signaling in CRF-induced modulation of startle.Single prolonged stress enhances hippocampal glucocorticoid receptor and phosphorylated protein kinase B levelsCaveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells.Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder.Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effectsAlternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity.Sex differences in the locus coeruleus-norepinephrine system and its regulation by stress.FKBP5 and attention bias for threat: associations with hippocampal function and shape.Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.Pharmacotherapy in the aftermath of trauma; opportunities in the 'golden hours'.Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond.The Effect of Nicotine on HPA Axis Activity in Females is Modulated by the FKBP5 Genotype.Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses.A putative causal relationship between genetically determined female body shape and posttraumatic stress disorder.Risperidone Attenuates Modified Stress-Re-stress Paradigm-Induced Mitochondrial Dysfunction and Apoptosis in Rats Exhibiting Post-traumatic Stress Disorder-Like Symptoms.Sex differences in neurosteroid and hormonal responses to metyrapone in posttraumatic stress disorder.Role of FKBP5 in emotion processing: results on amygdala activity, connectivity and volume.Molecular and Cellular Effects of Traumatic Stress: Implications for PTSD.
P2860
Q28083084-A5E0B47A-D0A2-4BB0-99B5-E458EA25AA03Q30429995-AE20E4B9-875B-4531-B988-903334DDD17FQ30443711-918F9EEE-2BF6-4019-92F4-9BDA7B9F394CQ33899866-7B5D65A7-C2D8-49E9-AC10-EF324CD886DDQ34472424-79A85911-4154-46E7-AA75-BEFB0C19DB54Q36515121-EC5506D9-3CFE-4A47-B1C3-32A1F565E214Q36860090-640AA7DB-67C9-49DC-B1AA-B7D2DC8CEC8CQ36923878-B3ED819D-1395-45AD-A725-742773C8ED75Q37066740-562973B6-059A-47FB-991F-16D834E05AD5Q37585127-76CF4941-8FD5-43BC-815E-FF4EEBF3F6BEQ38217123-0C27C7AD-FF58-4B46-BB37-BBAF8B561413Q38832608-CA0EA523-EC16-415C-9B3A-4A7B2A7016DBQ38883411-79E89EB6-0B46-43F7-9AD0-6C86B0A63304Q42527577-3E029DD8-C596-4217-8AFD-1CDDBE8CD9E1Q45074061-45AC5E07-6BFF-4213-8256-A74878B91D2CQ47738847-B3FDB0B7-68B5-4818-BC2C-3907702B7BC5Q47854333-7C0FA561-2DBF-4E78-B4E9-8A98D17E4CDEQ47885230-A1907246-605A-43BC-95BA-CC3D75CEB606Q47931276-D0908024-F782-4938-9088-06DCF307FFF4
P2860
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
@ast
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
@en
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
@nl
type
label
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
@ast
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
@en
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
@nl
prefLabel
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
@ast
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
@en
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
@nl
P2093
P2860
P921
P1433
P1476
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
@en
P2093
Frank M. Dautzenberg
J. Alberto Olivares-Reyes
James B. Lohr
Richard L. Hauger
Robert H. Oakley
Sandra Braun
P2860
P304
P356
10.1016/J.NEUROPHARM.2011.11.007
P407
P577
2012-02-01T00:00:00Z